Corrigendum to “Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3+ CD8+ T Cells and Survival in Diffuse Large B Cell Lymphoma”
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2021/4972043 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849404502154674176 |
|---|---|
| author | Tingting Zhang Tianyuan Ren Zheng Song Jing Zhao Lei Jiao Zhenzhen Zhang Jin He Xianming Liu Lihua Qiu Lanfang Li Shiyong Zhou Bin Meng Qiongli Zhai Xiubao Ren Zhengzi Qian Xianhuo Wang Huilai Zhang |
| author_facet | Tingting Zhang Tianyuan Ren Zheng Song Jing Zhao Lei Jiao Zhenzhen Zhang Jin He Xianming Liu Lihua Qiu Lanfang Li Shiyong Zhou Bin Meng Qiongli Zhai Xiubao Ren Zhengzi Qian Xianhuo Wang Huilai Zhang |
| author_sort | Tingting Zhang |
| collection | DOAJ |
| format | Article |
| id | doaj-art-906891ef9a8e427383e6730d349ebad5 |
| institution | Kabale University |
| issn | 2314-8861 2314-7156 |
| language | English |
| publishDate | 2021-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Immunology Research |
| spelling | doaj-art-906891ef9a8e427383e6730d349ebad52025-08-20T03:36:58ZengWileyJournal of Immunology Research2314-88612314-71562021-01-01202110.1155/2021/49720434972043Corrigendum to “Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3+ CD8+ T Cells and Survival in Diffuse Large B Cell Lymphoma”Tingting Zhang0Tianyuan Ren1Zheng Song2Jing Zhao3Lei Jiao4Zhenzhen Zhang5Jin He6Xianming Liu7Lihua Qiu8Lanfang Li9Shiyong Zhou10Bin Meng11Qiongli Zhai12Xiubao Ren13Zhengzi Qian14Xianhuo Wang15Huilai Zhang16Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, The Sino-US Center for Lymphoma and Leukemia Research, Tianjin, ChinaDepartment of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, The Sino-US Center for Lymphoma and Leukemia Research, Tianjin, ChinaDepartment of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, The Sino-US Center for Lymphoma and Leukemia Research, Tianjin, ChinaDepartment of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, The Sino-US Center for Lymphoma and Leukemia Research, Tianjin, ChinaPanovue Biological Technology Co., Ltd., Beijing, ChinaMarvel Medical Laboratory, Tianjin Marvelbio Technology Co. Ltd., Tianjin, ChinaDepartment of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, The Sino-US Center for Lymphoma and Leukemia Research, Tianjin, ChinaDepartment of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, The Sino-US Center for Lymphoma and Leukemia Research, Tianjin, ChinaDepartment of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, The Sino-US Center for Lymphoma and Leukemia Research, Tianjin, ChinaDepartment of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, The Sino-US Center for Lymphoma and Leukemia Research, Tianjin, ChinaDepartment of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, The Sino-US Center for Lymphoma and Leukemia Research, Tianjin, ChinaDepartment of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, ChinaDepartment of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, ChinaDepartment of Immunology/Biotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, ChinaDepartment of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, The Sino-US Center for Lymphoma and Leukemia Research, Tianjin, ChinaDepartment of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, The Sino-US Center for Lymphoma and Leukemia Research, Tianjin, ChinaDepartment of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, The Sino-US Center for Lymphoma and Leukemia Research, Tianjin, Chinahttp://dx.doi.org/10.1155/2021/4972043 |
| spellingShingle | Tingting Zhang Tianyuan Ren Zheng Song Jing Zhao Lei Jiao Zhenzhen Zhang Jin He Xianming Liu Lihua Qiu Lanfang Li Shiyong Zhou Bin Meng Qiongli Zhai Xiubao Ren Zhengzi Qian Xianhuo Wang Huilai Zhang Corrigendum to “Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3+ CD8+ T Cells and Survival in Diffuse Large B Cell Lymphoma” Journal of Immunology Research |
| title | Corrigendum to “Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3+ CD8+ T Cells and Survival in Diffuse Large B Cell Lymphoma” |
| title_full | Corrigendum to “Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3+ CD8+ T Cells and Survival in Diffuse Large B Cell Lymphoma” |
| title_fullStr | Corrigendum to “Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3+ CD8+ T Cells and Survival in Diffuse Large B Cell Lymphoma” |
| title_full_unstemmed | Corrigendum to “Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3+ CD8+ T Cells and Survival in Diffuse Large B Cell Lymphoma” |
| title_short | Corrigendum to “Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3+ CD8+ T Cells and Survival in Diffuse Large B Cell Lymphoma” |
| title_sort | corrigendum to genetic mutations of tim 3 ligand and exhausted tim 3 cd8 t cells and survival in diffuse large b cell lymphoma |
| url | http://dx.doi.org/10.1155/2021/4972043 |
| work_keys_str_mv | AT tingtingzhang corrigendumtogeneticmutationsoftim3ligandandexhaustedtim3cd8tcellsandsurvivalindiffuselargebcelllymphoma AT tianyuanren corrigendumtogeneticmutationsoftim3ligandandexhaustedtim3cd8tcellsandsurvivalindiffuselargebcelllymphoma AT zhengsong corrigendumtogeneticmutationsoftim3ligandandexhaustedtim3cd8tcellsandsurvivalindiffuselargebcelllymphoma AT jingzhao corrigendumtogeneticmutationsoftim3ligandandexhaustedtim3cd8tcellsandsurvivalindiffuselargebcelllymphoma AT leijiao corrigendumtogeneticmutationsoftim3ligandandexhaustedtim3cd8tcellsandsurvivalindiffuselargebcelllymphoma AT zhenzhenzhang corrigendumtogeneticmutationsoftim3ligandandexhaustedtim3cd8tcellsandsurvivalindiffuselargebcelllymphoma AT jinhe corrigendumtogeneticmutationsoftim3ligandandexhaustedtim3cd8tcellsandsurvivalindiffuselargebcelllymphoma AT xianmingliu corrigendumtogeneticmutationsoftim3ligandandexhaustedtim3cd8tcellsandsurvivalindiffuselargebcelllymphoma AT lihuaqiu corrigendumtogeneticmutationsoftim3ligandandexhaustedtim3cd8tcellsandsurvivalindiffuselargebcelllymphoma AT lanfangli corrigendumtogeneticmutationsoftim3ligandandexhaustedtim3cd8tcellsandsurvivalindiffuselargebcelllymphoma AT shiyongzhou corrigendumtogeneticmutationsoftim3ligandandexhaustedtim3cd8tcellsandsurvivalindiffuselargebcelllymphoma AT binmeng corrigendumtogeneticmutationsoftim3ligandandexhaustedtim3cd8tcellsandsurvivalindiffuselargebcelllymphoma AT qionglizhai corrigendumtogeneticmutationsoftim3ligandandexhaustedtim3cd8tcellsandsurvivalindiffuselargebcelllymphoma AT xiubaoren corrigendumtogeneticmutationsoftim3ligandandexhaustedtim3cd8tcellsandsurvivalindiffuselargebcelllymphoma AT zhengziqian corrigendumtogeneticmutationsoftim3ligandandexhaustedtim3cd8tcellsandsurvivalindiffuselargebcelllymphoma AT xianhuowang corrigendumtogeneticmutationsoftim3ligandandexhaustedtim3cd8tcellsandsurvivalindiffuselargebcelllymphoma AT huilaizhang corrigendumtogeneticmutationsoftim3ligandandexhaustedtim3cd8tcellsandsurvivalindiffuselargebcelllymphoma |